Loading...
Projects / Programmes source: ARIS

Bolezni in povzročitelji, ki jih v Sloveniji prenašajo členonožci (Slovene)

Periods
Research activity

Code Science Field Subfield
3.01.00  Medical sciences  Microbiology and immunology   

Code Science Field
B510  Biomedical sciences  Infections 
Evaluation (rules)
source: COBISS
Researchers (25)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  16235  PhD Maja Arnež  Microbiology and immunology  Researcher  2004 - 2008  184 
2.  27886  PhD Petra Bogovič  Microbiology and immunology  Technical associate  2008  148 
3.  13302  PhD Jože Cimperman  Microbiology and immunology  Researcher  2004 - 2008  180 
4.  24040  PhD Milan Črv  Microbiology and immunology  Researcher  2004 - 2008  17 
5.  13300  PhD Matjaž Jereb  Microbiology and immunology  Researcher  2007 - 2008  251 
6.  13670  MSc Tomaž Jurca  Oncology  Technical associate  2005 - 2008  85 
7.  16183  PhD Mateja Logar  Microbiology and immunology  Researcher  2004 - 2008  248 
8.  13299  PhD Stanka Lotrič Furlan  Microbiology and immunology  Researcher  2004 - 2008  335 
9.  13298  PhD Vera Maraspin-Čarman  Microbiology and immunology  Researcher  2004 - 2008  255 
10.  11348  PhD Mojca Matičič  Microbiology and immunology  Researcher  2004 - 2008  367 
11.  20254  PhD Katarina Ogrinc  Microbiology and immunology  Researcher  2004 - 2008  89 
12.  13297  PhD Franjo Pikelj  Microbiology and immunology  Researcher  2004 - 2008  104 
13.  18371  PhD Andreja Pikelj Pečnik  Microbiology and immunology  Researcher  2004 - 2008  61 
14.  11346  Dušica Pleterski-Rigler  Microbiology and immunology  Technical associate  2005 - 2006  109 
15.  20473  Mateja Poljanšek    Technical associate  2004 - 2008 
16.  27866  Jan Porekar  Computer science and informatics  Researcher  2007  27 
17.  27603  PhD Anja Radšel  Microbiology and immunology  Junior researcher  2007 - 2008  41 
18.  22350  PhD Tereza Rojko  Microbiology and immunology  Researcher  2004 - 2008  109 
19.  20474  Simona Rojs    Technical associate  2004 - 2008 
20.  20475  Andreja Sorman    Technical associate  2004 - 2008 
21.  13301  PhD Franc Strle  Microbiology and immunology  Head  2004 - 2008  845 
22.  24091  PhD Daša Stupica  Microbiology and immunology  Technical associate  2005 - 2008  177 
23.  20477  Dragica Štucin    Technical associate  2004 - 2008 
24.  11347  PhD Janez Tomažič  Microbiology and immunology  Researcher  2004 - 2008  412 
25.  20472  Marija Žitko    Technical associate  2004 - 2008 
Organisations (1)
no. Code Research organisation City Registration number No. of publicationsNo. of publications
1.  0312  University Medical Centre Ljubljana  Ljubljana  5057272000  77,498 
Significance for science
Ad 1. The efficacy of the antibiotics assessed for treatment of erythema migrans was comparable, but pronounce distinctions in costs of treatment was found. We expect that the acquired data will enable more rational choice of antibiotics for the treatment of erythema migrans. Ad 2. Obtaining data not available in the literature. Data on persistence of borreliae in skin after treatment with antibiotics will enable rational choice of drugs for treatment of erythema migrans. Such findings may influence treatment approaches not only in patients with erythema migrans but also in patients with other manifestations of Lyme borreliosis. Ad 3. Completion of very limited information. If the clinical course and outcome of early Lyme borreliosis is found more severe or less favorable in immunocompromised than in immunocompetent hosts further studies with more aggressive treatment or longer therapy with antibiotics might be warranted for immunocompromised patients. However, our findings in patients with solid organ transplants indicate that treatment of early Lyme borreliosis may be the same as for non-immunocompromised patients. Ad 4. Completion of very rare data. If our research will confirm that there really exist differences between age groups, this will enable a more reasonable interpretation of the differences reported for groups of patients with erythema migrans, including a greater or smaller number of pediatric (or elderly) patients; in addition, such differences will give rise to new questions about the importance of immune mechanisms in the pathogenesis of the disease. Ad 5. Obtaining data not available in the literature. Data will enable an insight into the pathogenesis of Lyme borreliosis. Ad 6. A comparative study on intrathecal production of borrelial antibodies and isolation of borrelia from the CSF will enable an insight into the pathogenesis of the disease and will have practical consequences for diagnostics of Lyme neuroborreliosis. Our initial findings indicate that intrathecal borrelial antibody production is more effective with B. garinii than with B. afzelii infection. Ad 7. Completion of limited information with potential consequences for the management of patients with suspected chronic Lyme borreliosis. Ad 8. Data on the frequency and mode of hearth involvement in the corse of early Lyme borreliosis was obtained. Ad 9. Obtaining data not available in the literature. Acquired information will permit an insight into the pathogenesis of Lyme borreliosis and will have highly valuable consequences for the management of patients with acrodermatitis chronica atrophicans. Ad 10. Obtaining data not available in the literature. If the occurence of clinically evident reinfections with B. burgdorferi sensu lato will be relatively high, difficulties with the efficacy of Lyme borreliosis vaccine can be anticipated. If clinical features of reinfection will be more pronounced than those of primary infection, persons vaccineted against Lyme borreliosis may develop (in case of infection with B. burgdorferi s.l.) more severe clinical signs of the disease than those who were unvaccinated. Ad 11. Provision of an insight into the cases of coinfection due to different tick-transmitted pathogens. If the results will demonstrate that leukopenia and thrombocytopenia observed in patients with erythema migrans reflect concomitant infection with ehrlichia (anaplasma), the treatment approach used in the management of erythema migrans will have to be changed, i.e. will have to be limited to the use of doxycycline. Ad 12. Insight into pathogenesis of transmission of infection with B. burgdorferi s.l., A. phagocytophilum, tick-borne encephalitis virus and babesiae as well as the relationship between the infection and disease. The obtained data are of potential importance for the rational approach to the prevention of tick-transmitted diseases and for the selection of target population groups for vaccination against Lyme borrelio
Significance for the country
All studies of the research programme (1.-12.) are of indirect importance for the society due to the promotion of the country through new knowledge. Studies with a potential of pronounced direct influence on health care and/or management of patients are listed herein: Ad 1. The obtained data will enable rational choice of antibiotics for treatment of erythema migrans and rational decisions on duration of the treatment. Ad 2. Data on persistence of borreliae in skin after treatment with antibiotics will enable rational choice of drugs for treatment of erythema migrans. In case that persistence is demonstrated in skin one can presume that it will occur also in other tissues, especially in those to which antibiotics have rather limited access (for example central nervous system). Such finding may influence treatment approaches not only in patients with erythema migrans but also in patients with other manifestations of Lyme borreliosis. Ad 5. Additional assessment of diagnostic value of serological testing of central nervous system infections with different Borrelia species will most probably be needed. Ad 7. and 9. The assessment of the efficacy of the two treatment approaches will enable rational antibiotic choice. Because no differences were found, future treatment of patients with suspected chronic Lyme borreliosis will consist of doxycycline, which is much less expensive drug in comparison to ceftriaxone. Similar approach will be used also for patients with acrodermatitis chronica atrophicans. Ad 11. If the results will demonstrate that leukopenia and thrombocytopenia observed in patients with erythema migrans reflect concomitant infection with ehrlichia (anaplasma), the treatment approach used in the management of erythema migrans will have to be changed, i.e. will have to be limited to the use of doxycycline. Ad 12. The obtained data will be of potential importance for the rational approach to the prevention of tick-transmitted diseases and for the selection of target population groups for vaccination against Lyme borreliosis in the future.
Most important scientific results Final report, complete report on dLib.si
Most important socioeconomically and culturally relevant results Final report, complete report on dLib.si
Views history
Favourite